Positive Patient Outcomes for Clients with SAB
University of Texas at El Paso
According to Lopez-Cortes et al. (2013) bacteremia is closely related to the state of morbidity of a patient and the outcome that follows this state, which may lead to chronic illness or even death. In the article, “Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia”, Lopez-Cortes et al. (2013) describes significant factors, like quality of care indicators (CQI), that have proven to be quantitative measures of crucial importance on prognosis and subsequent treatment of this disease. Correspondingly, a research article conducted by Holmes et al. (2011), “Antibiotic choice may not explain poorer outcomes in patients with staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations”, denotes the importance of analysis-based augmentation of the minimum inhibitory concentration of antibiotics when dealing with blood infections in order to acquire more favorable outcomes. Additionally, a patient case was selected to address and dissect two topics: 1) the medical care that the patient received and how can treatment be improved according to the evidenced based practice article selected and 2) how can treatment be improved with results from the research article selected.
Bacteremia is the infection of the blood with an agent that is foreign to the blood itself. Various alien agents may be able to infiltrate the previous sterile circulatory system, but only Staphylococcus aureus will be taken into consideration in this paper. According to Thwaites et al. (2011) infection of the blood with S. aureus is one of the most life threatening bacterial infections around the world; 12,500 cases are reported in the United Kingdom alone. Out of these reported cases, 3750 people will expire from Staphylococcus aureus bacteremia (SAB). Thwaites et al. (2011) explains that this mortality rate is due to inadequate treatment and unsatisfactory management of the disease. Subsequently, Holmes et al. (2011) explain that the relationship between the antibiotics used to treat SAB and the minimum inhibitory concentration has to be higher in order to better control the systemic infection. In relation to this increase in vancomycin dosage, Holmes et al. (2011) argues that the dosage to surpass the minimum inhibitory concentration is not directly related to the elevated rating of mortality as previously believed. In contrast, the high mortality rate was due to the patient’s age, treatment of hemodialysis (as the patient picked for this case analysis), device associated or nosocomial infection of SAB. As a whole, this leads to the conclusion that increased vancomycin dosage use to treat SAB may be a possibility that can be furthered investigated and tested for future positive patient outcomes.
Aforementioned, Lopez-Cortes et al. (2013) indicates the...